Treatment of interstitial cystitis with vitamin D compounds

Details for Australian Patent Application No. 2005216651 (hide)

Owner BioXell SpA

Inventors Colli, Enrico

Agent Davies Collison Cave

Pub. Number AU-A-2005216651

PCT Pub. Number WO2005/082375

Priority PCT/ US2004/031532 24.09.04 US; 0404571.2 01.03.04 GB; 0404567.0 01.03.04 GB

Filing date 1 March 2005

Wipo publication date 9 September 2005

International Classifications

C07C 401/00 (2006.01) Irradiation products of cholesterol or its derivatives

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/082375 Priority application(s): WO2005/082375

19 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216663-Topical compositions associating sodium hyaluronate fragments and retinoid useful for cosmetic and medical dermatology

2005216649-Use of methylene amide derivatives in cardiovascular disorders